EP1750713 - Bibliographic data
USE OF IMATINIB TO TREAT LIVER DISORDERS AND VIRAL INFECTIONS
Last update | 18/05/2025 |
---|---|
Legal status | Brevet déchu |
Origin | Euro-PCT |
(73) Holder |
BIONICHE LIFE SCIENCES INC. 231 Dundas St. East
Belleville, Ontario K8N 1E2
Canada
|
---|---|
(72) Inventors |
RIVIERE, Phillippe Château Malfart
F-33910 Saint Martin de Laye
France
RIVIERE, Marc 140 avenue Putney
Saint Lambert, Québec J4P 3B1
Canada
READER, Stéphanie 1791 d`Argenson
Ste-Julie, Quebec J3E 1E3
Canada
|
(74) Agent |
Mail recipient HOLMBERG, MARTIN TOR Bergenstrahle & Lindvall AB P.O. Box 17704
118 93 Stockholm
Suède
|
(21) Request number | EP05752861.4 |
---|---|
(22) Request date | 03/06/2005 |
(11) Publication number | EP1750713 |
---|---|
Publication date | 17/10/2012 |
(54) Title of the invention | USE OF IMATINIB TO TREAT LIVER DISORDERS AND VIRAL INFECTIONS |
---|---|
(51) International classification | A61K 31/506, A61P 31/12, A61P 31/14 |
International classification (before reform) | None |
Claimed priority |
(31) Number: 576573 P |
---|---|
Initial application | None |
Divisional application | None |
Expected annuity |
Annuity: 9 -
Amount: 120 € -
Due date 01/07/2013
Surtax: 9 - Amount: 24 € - Due date 02/01/2014 |
---|---|
Last annuity | None |
Publication | BREVETS D'INVENTION DESIGNANT MC DELIVRES PAR l'OEB - bulletin 2012/4, of 31/12/2012 |
---|---|
History | Publication de la délivrance du brevet européen - Legal date 17/10/2012 Entrée en période de grâce du brevet d'invention - Legal date 01/07/2013 Déchéance du brevet d'invention après période de grâce - Legal date 01/07/2013 |